DHR vs ORCL: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Oracle Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Oracle Corporation · Technology
$175.08
+137.3% upside to fair value
Grade C
High Quality
QuantHub Verdict
ORCL has more upside to fair value
(+137.3%).
ORCL trades at a lower forward P/E
(30.8x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
ORCL |
| Current Price |
$174.04 |
$175.08 |
| Fair Value Estimate |
$197.01 |
$415.43 |
| Upside to Fair Value |
+13.2%
|
+137.3%
|
| Market Cap |
$123.2B |
$503.5B |
| Forward P/E |
33.4x
|
30.8x
|
| EV / EBITDA |
20.3x
|
21.4x
|
| Price / Sales |
5.0x
|
7.9x
|
| Price / FCF |
23.3x
|
-20.4x
|
| Revenue Growth YoY |
+3.7%
|
+21.7%
|
| Gross Margin |
60.7%
|
66.4%
|
| Operating Margin |
21.0%
|
30.8%
|
| Return on Equity |
7.1%
|
57.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
—
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Oracle Corporation is a leading enterprise software and cloud infrastructure provider with a strong legacy in database technology and a growing cloud business. The company benefits from a durable competitive moat supported by high insider ownership, experienced leadership, and a history of strategic acquisitions. Oracle's recent financials show robust revenue growth of 21.7% and earnings growth o…
Accumulation Zones
| Metric |
DHR |
ORCL |
| Zone Low |
$147.76 |
$311.57 |
| Zone High |
$167.46 |
$353.12 |
| In Buy Zone? |
No
|
Yes
|